Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
How We Evaluate and Treat Leukemic Presentations of Mature T-Cell Lymphomas.
Journal: Cancers
Published: January 04, 2026
Aplastic anemia in association with multiple myeloma: clinical and pathophysiological insights.
Journal: Leukemia & lymphoma
Published: September 03, 2024
Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
Journal: The American journal of case reports
Published: November 29, 2022
Safety considerations with the current treatments for peripheral T-cell lymphoma.
Journal: Expert opinion on drug safety
Published: February 07, 2022
How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
Journal: British journal of haematology
Published: May 14, 2021
Joining Efforts for PTLD: Lessons Learned from Comparing the Approach and Treatment Strategies Across the Pediatric and Adult Age Spectra.
Journal: Current hematologic malignancy reports
Published: January 27, 2021
Prolonged progression free survival in a subset of responders to the combination of brentuximab vedotin and bendamustine in heavily treated patients with relapsed or refractory Hodgkin lymphoma: updated results from an international multi-center phase I/II experience.
Journal: Leukemia & lymphoma
Published: July 29, 2020
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas.
Journal: Haematologica
Published: July 17, 2020
Generation of pralatrexate resistant T-cell lymphoma lines reveals two patterns of acquired drug resistance that is overcome with epigenetic modifiers.
Journal: Genes, chromosomes & cancer
Published: May 14, 2020
Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.
Journal: Molecular cancer therapeutics
Published: May 06, 2020
Last Updated: 09/26/2026